Join us on Sunday prior to BIO-Europe Our annual Pre-BIO-Europe BYO primer will be held at O'Leary's on Sunday, November 3 at 5 pm (or, 1700, if you prefer).O'Leary's is located…
How much does it cost to develop a drug?We still don't know. The most recent analysis on this subject was published earlier this year. In an excellent analysis, Sertkaya et al. analyzed…
This article was triggered by a beverage-induced discussion I had with Martin Eglitis at BIO-Europe earlier this month. In my licensing courses, I spend a bit of time talking about the probability…
Congratulations! You have successfully advanced your drug candidate to the point where it is ready for out-licensing (or so you believe, anyway). You believe that now is the time to…
The US FDA recently published an interesting discussion paper, entitled Using Artificial Intelligence & Machine Learning in the Development of Drug and Biological Products. Here is a link to the…
It seems as if nobody talks about anything except AI these days, especially in the drug discovery part of our industry. And why not? In a relatively short period of…
Biotech industry poised for boom: 2023 licensing & M&A predictions.
Why don't companies write business plans anymore? Are they useless? Is it simply faster to put together 10 slides? In this post, we discuss this interesting question.
https://youtu.be/69azx95XaGQ Here is our annual year in review, along with some predictions (which are rarely correct) for 2023.
https://youtu.be/nXkNQpLNz-M We recently completed a Scouting project on behalf of a geographically-focused company. In this video, we discuss some of the lessons learned. We also provide some suggestions for addressing…